-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
Wales boss Tandy expects Rees-Zammit to make bench impact against the Pumas
-
James Watson, Nobel prize-winning DNA pioneer, dead at 97
-
Medical all-clear after anti-Trump package opened at US base
-
Sabalenka beats Anisimova in pulsating WTA Finals semi
-
Iran unveils monument to ancient victory in show of post-war defiance
-
MLS Revolution name Mitrovic as hew head coach
-
Brazil court reaches majority to reject Bolsonaro appeal against jail term
-
Norris grabs pole for Brazilian Grand Prix sprint race
-
More than 1,200 flights cut across US in govt paralysis
-
NFL Cowboys mourn death of defensive end Kneeland at 24
-
At COP30, nations target the jet set with luxury flight tax
-
Trump hosts Hungary's Orban, eyes Russian oil sanctions carve-out
-
All Blacks 'on edge' to preserve unbeaten Scotland run, says Savea
-
Alpine say Colapinto contract about talent not money
-
Return of centuries-old manuscripts key to France-Mexico talks
-
Byrne adamant Fiji no longer overawed by England
-
Ex-footballer Barton guilty over 'grossly offensive' X posts
-
Key nominees for the 2026 Grammy Awards
-
Brazil court mulls Bolsonaro appeal against jail term
-
Rybakina sinks Pegula to reach WTA Finals title match
-
Earth 'can no longer sustain' intensive fossil fuel use, Lula tells COP30
-
Kendrick Lamar leads Grammy noms with nine
-
Ex-British soldier fights extradition over Kenyan woman's murder
-
Kolisi to hit Test century with his children watching
-
Alex Marquez fastest in practice ahead of Portuguese MotoGP
-
Will 'war profiteer' Norway come to Ukraine's financial rescue?
-
Tech selloff drags stocks down on AI bubble fears
-
Blasts at Indonesia school mosque injure more than 50
-
Contepomi says lead-in to Wales match a 'challenge' for Argentina
-
Greece woos US energy deals, as eco groups cry foul
-
Frank says Spurs supporting Udogie through 'terrible situation'
-
MSF warns of missing civilians in Sudan's El-Fasher
-
Norris on top as McLaren dominate opening Sao Paulo practice
-
UN warns 'intensified hostilities' ahead in Sudan despite RSF backing truce plan
-
Seven hospitalized after suspicious package opened at US base
-
Guardiola says 'numbers are insane' as he reaches 1,000 games in charge
-
Brazil welcomes China lift of ban on poultry imports
-
Scotland captain Tuipulotu bids for landmark win over All Blacks
-
Woman convicted in UK of harassing Maddie McCann's parents
-
Tanzania charges more than 100 with treason over election protests
-
Nexperia chip exports resuming: German auto supplier
-
Genge warns England to beware 'nasty' Fiji at Twickenham
-
Stocks fall on renewed AI bubble fears
-
UK grandmother on Indonesia death row arrives back in London
-
Spanish star Rosalia reaches for divine in new album
-
Portugal's Mendes out injured as Neves returns for World Cup qualifiers
-
Afghan-Pakistan peace talks push ahead after border clashes
-
Fleetwood in tie for lead at halfway stage in Abu Dhabi
-
Brazil court starts hearing Bolsonaro appeal
Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
P.Martin--AMWN